Acetylcysteine
Nisha Patel, PharmD, MBA, BCPS, Alona Crowder, Pharm.D.
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
- Adjuvant mucolytic therapy for patients with abnormal, viscid, or inspissated mucous secretions secondary to respiratory diseases such as emphysema, tuberculosis, bronchitis or for treatment of respiratory complications of cystic fibrosis and tracheostomy care.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Nephrotoxicity prophylaxis (focus of this module)
- Acetaminophen overdose
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.